JPS63203162A - Gel matrix - Google Patents
Gel matrixInfo
- Publication number
- JPS63203162A JPS63203162A JP62035750A JP3575087A JPS63203162A JP S63203162 A JPS63203162 A JP S63203162A JP 62035750 A JP62035750 A JP 62035750A JP 3575087 A JP3575087 A JP 3575087A JP S63203162 A JPS63203162 A JP S63203162A
- Authority
- JP
- Japan
- Prior art keywords
- water
- parts
- gel matrix
- gel
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011159 matrix material Substances 0.000 title claims description 11
- 239000003431 cross linking reagent Substances 0.000 claims description 9
- 150000005846 sugar alcohols Polymers 0.000 claims description 9
- 229920003169 water-soluble polymer Polymers 0.000 claims description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 235000021419 vinegar Nutrition 0.000 claims 1
- 239000000052 vinegar Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000463 material Substances 0.000 description 11
- 239000000017 hydrogel Substances 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 3
- 241000288673 Chiroptera Species 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012774 insulation material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- -1 aluminum compound Chemical class 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- SAPGTCDSBGMXCD-UHFFFAOYSA-N (2-chlorophenyl)-(4-fluorophenyl)-pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(F)C=C1 SAPGTCDSBGMXCD-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- CUGZWHZWSVUSBE-UHFFFAOYSA-N 2-(oxiran-2-ylmethoxy)ethanol Chemical compound OCCOCC1CO1 CUGZWHZWSVUSBE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 101100328086 Caenorhabditis elegans cla-1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000007718 adhesive strength test Methods 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- UTUUIUQHGDRVPU-UHFFFAOYSA-K aluminum;2-aminoacetate;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Al+3].NCC([O-])=O UTUUIUQHGDRVPU-UHFFFAOYSA-K 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は褥癒予防、治療バット、放香材、保温材、fj
J in保護材として利用され(qるゲルマトリックス
に関するものである。[Detailed Description of the Invention] [Industrial Application Field] The present invention is applicable to bedsore prevention, treatment bats, scented materials, heat insulating materials, fj
It relates to a gel matrix that is used as a protective material.
[従来の技術]
従来より、ゼラチン、アルギン酸ソーダ、カルボキシメ
チルセルロース、ヒドロキシエチルセルロース、デンプ
ン等の天然高分子ないし天然高分子誘導体、ポリビニル
アルコール、ポリアクリル酸、ポリビニルピロリドン、
カルボキシビニルポリマー等の合成高分子を利用した含
水ゲル、さらには油性ゴム等の疎水性ポリマーに含水さ
せた含水ゲル等が、保冷材、保湿材、放香材、創傷保護
材、治療バット等の各種用途に広く用いられてきた。[Prior Art] Conventionally, natural polymers or natural polymer derivatives such as gelatin, sodium alginate, carboxymethyl cellulose, hydroxyethyl cellulose, starch, polyvinyl alcohol, polyacrylic acid, polyvinylpyrrolidone,
Hydrogels made from synthetic polymers such as carboxyvinyl polymers, and hydrogels made by impregnating hydrophobic polymers such as oil-based rubber, are used for cold insulation materials, moisturizing materials, fragrance materials, wound protection materials, therapeutic bats, etc. It has been widely used for various purposes.
例えば、特開昭55−20726号公報には△BA星型
ブロックポリマーに含水させた油性含水ゲル、特開昭5
5−102653号公報にはゴムラテックスを用いた油
性含水ゲル、特開昭56−18917号公報にはマレイ
ン酸共重合体等をアルミニウム架橋させた含水ゲル、特
開昭57−128734号公報にはポリビニルアルコー
ル含水ゲル、特公昭58−23410@公報にはポリビ
ニルアルコール/ゼラチンよりなるものを架橋させ含水
ゲル、特公昭59−10695号公報にはスチレン−イ
ソプレン−スチレンブロック共重合体等を利用した油性
含水ゲル、特開昭59〜93012号公報にはポリアク
リル酸ソーダを金属架橋させた含水ゲル、特公昭61−
21251 @公報には液状ゴムに含水させ架橋させた
含水ゲル、特開昭61−106603号公報にはアクリ
ル酸を金属重合させた含水ゲル、特公明61−4192
6号公報には脂肪族カルボン酸をアルミニウム化合物で
架橋させた含水ゲル、また特公昭61−50493号公
報にはマレイン酸系共重合体を多価アミンで架橋した含
水グルがそれぞれ開示されている。For example, JP-A-55-20726 discloses an oil-based water-containing gel made of △BA star-shaped block polymer.
No. 5-102653 discloses an oil-based hydrogel using rubber latex, JP-A-56-18917 discloses a hydrogel containing a maleic acid copolymer cross-linked with aluminum, and JP-A-57-128734 discloses a hydrogel containing aluminum crosslinking. Polyvinyl alcohol hydrogel, Japanese Patent Publication No. 58-23410 @ a hydrogel made by crosslinking polyvinyl alcohol/gelatin, and Japanese Patent Publication No. 59-10695 an oil-based gel using styrene-isoprene-styrene block copolymer, etc. Water-containing gel, JP-A-59-93012, describes a water-containing gel in which sodium polyacrylate is cross-linked with metal,
21251 @ publication describes a hydrous gel obtained by impregnating liquid rubber with water and crosslinking it, and JP-A No. 61-106603 discloses a hydrous gel obtained by metal polymerizing acrylic acid, and JP-A-61-4192
Publication No. 6 discloses a hydrous gel made by crosslinking an aliphatic carboxylic acid with an aluminum compound, and Japanese Patent Publication No. 61-50493 discloses a hydrous gel made by crosslinking a maleic acid copolymer with a polyvalent amine. .
[発明が解決しようとする問題点]
上記したこれらの従来の方法によれば、いずれの場合に
おいても、多かれ少なかれ水の存在が必須であり、揮散
性の水が介在する限り次のような〜 欠点を有する。[Problems to be Solved by the Invention] According to the above-mentioned conventional methods, the presence of more or less water is essential in any case, and as long as volatile water is present, the following ~ It has its drawbacks.
1、水分を比較的容易に離脱し易く初期の特性を保持し
難い。1. Moisture is released relatively easily and it is difficult to maintain the initial properties.
2、人体と接触して使用する場合、補助貼付手段が必要
である。2. When used in contact with the human body, auxiliary application means are required.
3、薬物を含有させようとする場合、水の影響のため、
薬物の分解等が起きやすい。3. When trying to contain drugs, due to the influence of water,
Decomposition of the drug is likely to occur.
4、水の凍結温度において、柔軟性を保持し難い。4. Difficult to maintain flexibility at freezing temperatures of water.
そこで、本発明者らは上記の点に鑑み、これらの欠点を
解決し得るゲルマトリックスを提供することを目的とし
、種々検討した結采、水の存在を排して構成し得るゲル
マトリックスが、これら上記の欠点を解消し実用に供し
得ることを見い出し本発明を完成させた。Therefore, in view of the above points, the present inventors aimed to provide a gel matrix that could solve these drawbacks. The present invention has been completed by discovering that these above-mentioned drawbacks can be overcome and put to practical use.
すなわち本発明は、分子内にヒドロキシル基および/ま
たはカルボキシル基を有し、かつ多価アルコールに可溶
性の水溶性高分子と、その架橋剤および多価アルコール
を必須成分とし構成される実質的に無水のゲルマトリッ
クスである。That is, the present invention provides a substantially anhydrous polymer comprising a water-soluble polymer having a hydroxyl group and/or a carboxyl group in the molecule and soluble in a polyhydric alcohol, a crosslinking agent thereof, and a polyhydric alcohol as essential components. gel matrix.
本発明に用いられる水溶性高分子とは、その分子内にヒ
ドロキシル基および/またはカルボキシル基を有し、か
つ多価アルコールに可溶性のものであり、例えばメチル
ビニルエーテル無水マレイン酸共重合体、イソブチレン
−無水マレイン酸共重合体、カルボキシ変性ポリビニル
アルコール、カルボキシメチルセルロース等が挙げられ
、中でも特にメチルビニルエーテル無水マレイン酸共重
合体、イソブチレン無水マレイン酸共重合体等が望まし
い。The water-soluble polymer used in the present invention has a hydroxyl group and/or a carboxyl group in its molecule and is soluble in polyhydric alcohol, such as methyl vinyl ether maleic anhydride copolymer, isobutylene- Examples include maleic anhydride copolymers, carboxy-modified polyvinyl alcohols, carboxymethyl cellulose, etc. Among them, methyl vinyl ether maleic anhydride copolymers, isobutylene maleic anhydride copolymers, etc. are particularly desirable.
この水溶性高分子の架橋剤としては、水溶性高分子のカ
ルボキシル基、ヒドロキシル基等の官能基に作用し架橋
不溶化させるもので、従来公知のものが使用できる。例
えば分子中に少なくとも2個以上のエポキシ基を有する
化合物、具体的にはポリエチレングリコールジグリシジ
ルエーテル、エチレングリコールジグリシジルエーテル
、グリセリンジグリシジルエーテル、グリセリントリグ
リシジルエーテル、プロピレングリコールジグリシジル
エーテル、グリセロールポリグリシジルエーテル等が挙
げられる。また、他の架橋剤としては多価金属化合物で
あり、例えば水酸化アルミニウム、塩化アルミニウム、
水酸化カルシウム、塩化カルシウム、水酸化マグネシウ
ム、硫酸カリウムアルミニウム等が挙げられる。As the crosslinking agent for this water-soluble polymer, those that act on functional groups such as carboxyl groups and hydroxyl groups of the water-soluble polymer to crosslink and insolubilize it, and conventionally known ones can be used. For example, compounds having at least two or more epoxy groups in the molecule, specifically polyethylene glycol diglycidyl ether, ethylene glycol diglycidyl ether, glycerin diglycidyl ether, glycerin triglycidyl ether, propylene glycol diglycidyl ether, glycerol polyglycidyl Examples include ether. Other crosslinking agents include polyvalent metal compounds, such as aluminum hydroxide, aluminum chloride,
Examples include calcium hydroxide, calcium chloride, magnesium hydroxide, potassium aluminum sulfate, and the like.
これら架橋剤の好ましい配合mは、水溶性高分子100
重量部に対して0.1〜30重量部、さらに好ましくは
1〜10重囚部である。架橋剤の配合囚がこの範囲を逸
脱すると、凝集性、保型性が低下したり粘着がなくなり
硬くなるという問題が生じる。A preferred blend m of these crosslinking agents is water-soluble polymer 100%
It is 0.1 to 30 parts by weight, more preferably 1 to 10 parts by weight. If the crosslinking agent content exceeds this range, there will be problems such as decreased cohesiveness and shape retention, and loss of adhesion and hardness.
また、本発明に用いられる多価アルコールとしては、エ
チレングリコール、ジエチレングリコール、トリエチレ
ングリコール、ポリエチレングリコール、プロピレング
リコール、ポリプロピレングリコール、グリセリン、1
,3−ブチレングリコール、1,4−ブチレングリコー
ル等が挙げられ、中でも特にグリセリン、1,3−ブチ
レングリコール、エチレングリコールが望ましい。In addition, the polyhydric alcohols used in the present invention include ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, polypropylene glycol, glycerin,
, 3-butylene glycol, 1,4-butylene glycol, etc., among which glycerin, 1,3-butylene glycol, and ethylene glycol are particularly preferred.
この多価アルコールと前記水溶性高分子との好ましい配
合比(重量比)は10: 0.5〜5.0、さらに好
ましくは10: 1,2〜2.5である。両者の配合
比がこの範囲を逸脱すると、保形性、凝集力が低下した
り、作業性が低下するという問題が生じる。The preferred blending ratio (weight ratio) of this polyhydric alcohol and the water-soluble polymer is 10:0.5-5.0, more preferably 10:1.2-2.5. If the blending ratio of the two deviates from this range, there will be problems such as a decrease in shape retention and cohesive force, and a decrease in workability.
本発明のゲルマトリックスには、上記の水溶性高分子、
その架橋剤および多価アルコールからなる必須成分に加
えて、従来公知の酸化防止剤、軟化剤、粘着付与剤、老
化防止剤、無機充填剤等の配合剤が適宜適量配合される
。The gel matrix of the present invention includes the above-mentioned water-soluble polymer,
In addition to the essential components consisting of the crosslinking agent and polyhydric alcohol, conventionally known compounding agents such as antioxidants, softeners, tackifiers, antiaging agents, and inorganic fillers are blended in appropriate amounts.
次に、本発明のゲルマトリックスの製造法としては、従
来より実施されているいずれの方法でも良いが、−例と
してニーグー中で多価アルコールと水溶性高分子を混合
、溶解させた後、架橋剤を添加混合しゲルマトリックス
とする。Next, as a method for producing the gel matrix of the present invention, any conventionally practiced method may be used. Add and mix the agent to form a gel matrix.
以上のようにして得られた本発明のゲルマトリックスは
、褥癒予防、治療バット、放香材、保温材、創傷保護材
、保冷材、パック剤、薬物除放剤等に有用である。The gel matrix of the present invention obtained as described above is useful for prevention of bed sores, treatment bats, fragrance materials, heat insulation materials, wound protection materials, cold insulation materials, packs, controlled drug release agents, and the like.
[実施例] 次に、本発明を実施例等に基づきさらに詳しく述べる。[Example] Next, the present invention will be described in more detail based on examples and the like.
実施例1 (ゲル放香材)
イソブチレン無水マレイン酸共重合体(商品名;イソパ
ン、■クラ−1)12重備品とグリセリン73重量部を
混合し、その後、架橋剤としてグリセロールポリグリシ
ジルエーテル0,8重ffi部を添加し、次いでフロー
ラルタイプの香料14.2重量部を添加混合後、容器に
注入しゲル化させた。Example 1 (Gel fragrance material) Isobutylene maleic anhydride copolymer (trade name: Isopan, ■Cla-1) 12-layer equipment and 73 parts by weight of glycerin were mixed, and then 0.0% and 0% glycerol polyglycidyl ether was added as a crosslinking agent. 8 parts of ffi were added, and then 14.2 parts by weight of a floral type fragrance were added and mixed, and then poured into a container and gelled.
このものは長期にわたって香料を放出し、放香材として
優れていることがわかった。It was found that this product releases fragrance over a long period of time and is excellent as a fragrance material.
実施例2 (創傷保護材)
メチルビニルエーテル無水マレイン酸共重合体(商品名
;ガントレット、G、A、F社製) 17.5重最部と
グリセリン80.0重量部を混合し、その後、架橋剤と
して硫酸カリウムアルミニウム0.8重母部を添加混合
し、次いでヒノキチオール1.71 fit部を添加混
合後、不織布に展延し創傷保護材とした。Example 2 (Wound protection material) Methyl vinyl ether maleic anhydride copolymer (trade name: Gauntlet, manufactured by G, A, F) 17.5 parts by weight and 80.0 parts by weight of glycerin were mixed, and then crosslinked. As an agent, 0.8 parts of potassium aluminum sulfate was added and mixed, and then 1.71 parts of hinokitiol was added and mixed, and the mixture was spread on a nonwoven fabric to prepare a wound protection material.
実施例3 (W癒バット)
イソブチレン無水マレイン酸共重合体(商品名:イソパ
ン、■クラレ%J)18.0重岱部とグリセリン79.
8重量部を混合し、その後、架橋剤としてエチレングリ
コールジグリシジルエーテル1.2重量部とイソプロピ
ルメチルフェノール1(o重量部を添加混合後、不織布
に展延しW渣バットとした。Example 3 (W healing bat) Isobutylene maleic anhydride copolymer (trade name: Isopan, ■Kuraray %J) 18.0 parts by weight and 79.9 parts by weight of glycerin.
After that, 1.2 parts by weight of ethylene glycol diglycidyl ether and 1 (o parts by weight) of isopropyl methylphenol were added and mixed as a crosslinking agent, and then spread on a nonwoven fabric to form a W residue batt.
参考例1
平均重合度20000のポリアクリル酸ナトリウム5重
量部を水80重置部に溶解した。一方、エチレングリコ
ールグリシジルエーテル0.5重1部を水10重量部に
溶解した。Reference Example 1 5 parts by weight of sodium polyacrylate having an average degree of polymerization of 20,000 was dissolved in 80 parts by weight of water. On the other hand, 0.5 parts by weight of ethylene glycol glycidyl ether was dissolved in 10 parts by weight of water.
次に、ポリアクリル酸ナトリウム水溶液を撹拌しつつ、
エチレングリコールジグリシジルエーテル水(f1’t
ilを添加混合して、約70℃に加温し、不織布上に展
延し、含水ゲルシートを得た。Next, while stirring the sodium polyacrylate aqueous solution,
Ethylene glycol diglycidyl ether water (f1't
il was added and mixed, heated to about 70°C, and spread on a nonwoven fabric to obtain a hydrogel sheet.
試験例
実施例2〜3および参考例1で得られたシート等につい
て、粘着力試験、加温変化試験、冷凍保存試験を行ない
、結果を第1表に示した。なお、粘着力((] /cd
)試験は、タック試験機(ピクマタツクテスター、(掬
東洋精機製)を用い測定した。Test Examples The sheets obtained in Examples 2 to 3 and Reference Example 1 were subjected to an adhesive strength test, a heating change test, and a frozen storage test, and the results are shown in Table 1. In addition, the adhesive strength ((] /cd
) The test was carried out using a tack tester (Pikma Tack Tester, manufactured by Kikutoyo Seiki Co., Ltd.).
また、加温変化(60℃×24時間)試験、冷凍保存(
−25℃)試験は、各ゲルの状態をその初期と経口後を
比較観察したものである。In addition, temperature change (60℃ x 24 hours) test, frozen storage (
-25°C) test was a comparative observation of the state of each gel at its initial stage and after oral administration.
第1表
第1表に示されるように、実施例2〜3のゲルマトリッ
クスは含水でないために、参考例1の含水ゲルに比較し
て、温度変化に対して安定であり、さらに初期の物性を
長期に渡って維持でき、また適度な粘着力も具備してお
り、産業上有用である。Table 1 As shown in Table 1, since the gel matrices of Examples 2 and 3 do not contain water, they are more stable against temperature changes than the hydrous gel of Reference Example 1, and their initial physical properties are can be maintained for a long period of time, and also has a suitable adhesive strength, making it industrially useful.
[発明の効果]
以上のような本発明のゲルマトリックスにおいては、下
記のごとき効果を奏する。[Effects of the Invention] The gel matrix of the present invention as described above has the following effects.
1、含水でないため水の飛散による物性の変化がなく、
初期の良好な物性がそのまま維持できる。1. Since it does not contain water, there is no change in physical properties due to water scattering.
The initial good physical properties can be maintained as they are.
2、柔軟であり、温度変化に対しても安定である。2. Flexible and stable against temperature changes.
3、薬物、香料等を安定に含ませることができ、長期に
わたって放出する。3. It can stably contain drugs, fragrances, etc. and release them over a long period of time.
4、適度な粘着性を保持するため、人体に補助手段なく
装着できる。4. It maintains appropriate adhesiveness, so it can be attached to the human body without any assistance.
5、水溶性高分子と多価アルコールを使用しているため
、環境の汚染がなく安全である。5. Since it uses water-soluble polymers and polyhydric alcohols, it is safe and does not pollute the environment.
手 続 ン山 −正 書 (自 発)
昭和63年5月90
特許庁長官 小 川 邦 夫 殿
1、事件の表示
昭和62年 特 許 願 第35750号2、発明の名
称
ゲルマトリックス
3、補正をする者
!Ji件との関係 特許出願人
住 所 佐賀県鳥栖市田代大官町408番地名称久光製
薬株式会社
代表者中冨博隆
4、代理人〒105
住 所 東京都港区虎ノ門二丁目8番1号自発補正
6、補正の対象
「明細書の発明の詳細な説明の欄」
7、補正の内容
■、明細書第2頁第13〜14行の“架橋させ含水ゲル
”を「架橋させた含水ゲル」に訂正する。Procedures Mountain - Original (spontaneous) May 90, 1988 Director General of the Patent Office Kunio Ogawa 1. Indication of the case 1988 Patent Application No. 35750 2. Name of the invention Gel Matrix 3. Amendment. Those who do! Relationship with the Ji case Patent applicant address 408 Tashiro Daikan-cho, Tosu City, Saga Prefecture Name Hisamitsu Pharmaceutical Co., Ltd. Representative Hirotaka Nakatomi 4, Agent 105 Address 2-8-1 Toranomon, Minato-ku, Tokyo Voluntary amendment 6. Target of amendment: “Detailed description of the invention column in the specification” 7. Contents of amendment ■: “Cross-linked hydrogel” in lines 13-14 of page 2 of the specification has been changed to “cross-linked hydrogel” correct.
2、同書第5頁第13行の“水酸化マグネシウム、”の
後に「ケイ酸アルミニウム、リン酸カルシウム、アルミ
ン酸マグネシウム、アルミニウムグリシネート、ヒドロ
タルサイト、」を加入する。2. Add "aluminum silicate, calcium phosphate, magnesium aluminate, aluminum glycinate, hydrotalcite" after "magnesium hydroxide" on page 5, line 13 of the same book.
3、同書第8頁第13行の“バットとした。“の次行に
次の文章を加入する。3. In the same book, page 8, line 13, add the following sentence to the line after "I decided to bat."
「実施例4(バック剤)“Example 4 (Backing agent)
Claims (1)
基を有し、かつ多価アルコールに可溶性の水溶性高分子
と、その架橋剤および多価アルコールとを含有すること
を特徴とする実質的に無水のゲルマトリツクス。A substantially anhydrous gel matrix characterized by containing a water-soluble polymer having a hydroxyl group and/or a carboxyl group in its molecule and soluble in a polyhydric alcohol, a crosslinking agent thereof, and a polyhydric alcohol. vinegar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62035750A JPS63203162A (en) | 1987-02-20 | 1987-02-20 | Gel matrix |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62035750A JPS63203162A (en) | 1987-02-20 | 1987-02-20 | Gel matrix |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63203162A true JPS63203162A (en) | 1988-08-23 |
JPH0572222B2 JPH0572222B2 (en) | 1993-10-08 |
Family
ID=12450499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62035750A Granted JPS63203162A (en) | 1987-02-20 | 1987-02-20 | Gel matrix |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63203162A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02180989A (en) * | 1989-04-01 | 1990-07-13 | Daicel Chem Ind Ltd | Low-temperature insulant |
JPH02180988A (en) * | 1989-04-01 | 1990-07-13 | Daicel Chem Ind Ltd | Low-temperature insulant |
US5480649A (en) * | 1990-11-09 | 1996-01-02 | Teikoku Seiaku Kabushiki Kaisha | Procaterol-containing preparation for application to the skin |
US8323693B2 (en) | 2002-03-14 | 2012-12-04 | Medrx Co., Ltd. | External preparation for wounds |
WO2022254979A1 (en) * | 2021-06-04 | 2022-12-08 | 花王株式会社 | Gel composition |
WO2022254980A1 (en) * | 2021-06-04 | 2022-12-08 | 花王株式会社 | Gel composition |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54151115A (en) * | 1978-05-18 | 1979-11-28 | Watanabe Yakuhin Kogyo Kk | Poultice |
JPS58105911A (en) * | 1981-12-14 | 1983-06-24 | メルク エンド カンパニー インコーポレーテッド | Anhydrous thixotropic composition |
JPS59110614A (en) * | 1982-12-17 | 1984-06-26 | Lion Corp | Preparation of poultice |
JPS6087215A (en) * | 1983-10-19 | 1985-05-16 | Mitsui Toatsu Chem Inc | Base of drug for external use |
JPS6099180A (en) * | 1983-11-04 | 1985-06-03 | Lion Corp | Aqueous tackifier composition |
JPS61261341A (en) * | 1985-05-15 | 1986-11-19 | Nitto Electric Ind Co Ltd | Water-containing elastomer composition |
-
1987
- 1987-02-20 JP JP62035750A patent/JPS63203162A/en active Granted
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54151115A (en) * | 1978-05-18 | 1979-11-28 | Watanabe Yakuhin Kogyo Kk | Poultice |
JPS58105911A (en) * | 1981-12-14 | 1983-06-24 | メルク エンド カンパニー インコーポレーテッド | Anhydrous thixotropic composition |
JPS59110614A (en) * | 1982-12-17 | 1984-06-26 | Lion Corp | Preparation of poultice |
JPS6087215A (en) * | 1983-10-19 | 1985-05-16 | Mitsui Toatsu Chem Inc | Base of drug for external use |
JPS6099180A (en) * | 1983-11-04 | 1985-06-03 | Lion Corp | Aqueous tackifier composition |
JPS61261341A (en) * | 1985-05-15 | 1986-11-19 | Nitto Electric Ind Co Ltd | Water-containing elastomer composition |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02180989A (en) * | 1989-04-01 | 1990-07-13 | Daicel Chem Ind Ltd | Low-temperature insulant |
JPH02180988A (en) * | 1989-04-01 | 1990-07-13 | Daicel Chem Ind Ltd | Low-temperature insulant |
US5480649A (en) * | 1990-11-09 | 1996-01-02 | Teikoku Seiaku Kabushiki Kaisha | Procaterol-containing preparation for application to the skin |
US8323693B2 (en) | 2002-03-14 | 2012-12-04 | Medrx Co., Ltd. | External preparation for wounds |
WO2022254979A1 (en) * | 2021-06-04 | 2022-12-08 | 花王株式会社 | Gel composition |
WO2022254980A1 (en) * | 2021-06-04 | 2022-12-08 | 花王株式会社 | Gel composition |
Also Published As
Publication number | Publication date |
---|---|
JPH0572222B2 (en) | 1993-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001078690A1 (en) | Patch containing anti-inflammatory agent | |
US20060198802A1 (en) | Cataplasm base and cataplasm using the same | |
JPS63203162A (en) | Gel matrix | |
JP2001302502A (en) | Indomethacin percutaneous patch material | |
JPH0794583B2 (en) | High water content polymer gel | |
JPH0662401B2 (en) | Ketoprofen-containing patch | |
JP3260412B2 (en) | Polymer gel composition | |
JPH08243377A (en) | Alcohol-containing gel body | |
JP3144895B2 (en) | Medical adhesive tape or sheet | |
JPH09143061A (en) | Percutaneous absorption preparation for analgesic | |
JP2001039864A (en) | Felbinac-containing plaster | |
JPH0271745A (en) | Water-contained gel composition | |
JPS61148116A (en) | Poultice | |
JPH0333686B2 (en) | ||
JPH013116A (en) | Plasma for patch | |
JPH09143060A (en) | Composition for water-containing gel plaster base | |
JPH06135828A (en) | Percutaneous absorption preparation | |
JP2887548B2 (en) | Hydrous skin external patch with improved usability | |
JPS63203613A (en) | Hydrophilic percutaneous administration preparation | |
JP2005529150A (en) | Matrix-type patch with bronchodilator | |
JPH0477425A (en) | Indomethacin-containing formulation for external use | |
JPH0331172B2 (en) | ||
JPS61233077A (en) | Patch | |
JPS61205209A (en) | Ointment for cataplasm | |
JPS61277613A (en) | Gelatinous drug composition for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |